Genetic Engineering Publications - GEG Tech top picks
36.6K views | +0 today
Follow
Genetic Engineering Publications - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
Hultquist et al. report a high-throughput platform for the efficient, multiplex editing
of host factors that control HIV infection in primary CD4+ T cells. Arrayed electroporation
of CRISPR/Cas9 ribonucleoproteins (RNPs) permits the rapid generation of isogenic
human cells with ablated candidate factors and identifies gene modifications that
provide viral resistance.
BigField GEG Tech's insight:

Here, the scientists adapted this methodology to a high-throughput platform for the efficient, arrayed editing of candidate host factors. CXCR4 or CCR5 knockout cells generated with this method are resistant to HIV infection in a tropism-dependent manner, whereas knockout of LEDGF or TNPO3 results in a tropism-independent reduction in infection. CRISPR/Cas9 RNPs can furthermore edit multiple genes simultaneously, enabling studies of interactions among multiple host and viral factors. Finally, in an arrayed screen of 45 genes associated with HIV integrase, they identified several candidate dependency/restriction factors, demonstrating the power of this approach as a discovery platform. This technology should accelerate target validation for pharmaceutical and cell-based therapies to cure HIV infection.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes

CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this study, the authors used the CRISPR/Cas9 system to transform Leu33-positive megakaryocyte-like DAMI cells and induced pluripotent stem (iPS) cells to the Pro33 allotype.

No comment yet.